BD - Diagnostic Systems: White Papers

Product Center

Technical Center Contact Information Documents Literature Requests Services Software Downloads

Learning Center

Order Center

Contact Us

About Us

Diagnostic Systems Home


	We invite your feedback as we continue to improve and expand the value of our Web site.

You are here: BD › Diagnostic Systems › Technical Center › Documents › White Papers

Technical Center
White Papers

Blood Culture

(Click column headings to sort items)

Description	Year	Literature #
Comparative Study of the Instrument Robustness of Automated Blood Culture Devices: BD BACTEC™ versus bioM�rieux BacT/Alert™	2007	LR222669
Differences in Time to Detection and Recovery of Mycobacterium tuberculosis between the MGIT 960 and the BacT/Alert MB Automated Culture Systems.	2007	LR222668
Effectiveness of the BACTEC™ Blood Culture Resin-based Antimicrobial Removal System with Fluoroquinolones, Antifungals, Daptomycin, Tigecycline and Polymyxin B.	2006	LR222473
Ability of BD BACTEC Plus Blood Culture Bottles versus BacT/Alert FAN Blood Culture Bottles to Detect Bacterial Pathogens in Samples Containing Vancomycin	2005	LR891
Ability of BD BACTEC Plus Blood Culture Bottles versus BacT/Alert FAN Blood Culture Bottles to Detect Bacterial Pathogens in Samples Containing Therapeutic Levels of Cefoxitin and Piperacillin/Tazobactam	2005	LR222337
Blood Culture Antimicrobial Removal Effectiveness of BD BACTEC Plus Media Versus BacT/ALERT FAN Media	2003	LR789
Advanced Interactive Epidemiology Reports utilizing the BD Phoenix� EpiCenter� System	2000	LR644
Incidence of Safe Sample Collection Procedures with the BacT/Alert™ Blood Culture System		LR848
Improving Sepsis Diagnosis: Key to Better Patient Outcomes, Higher Reimbursement		LR888

Collection and Transport

(Click column headings to sort items)

Description	Year	Literature #
Comparison of StarSwab II with BD CultureSwab™ Max V(+) Transport Systems for Preservation of Bacterial Pathogens Important in Pediatric Medicine; Hemophilus influenza, Streptococcus pneumoniae,and Neisseria meningitidis	2005	LR222319
Comparative Study of the Viability of Clinically Important Bacteria in Two New Amies Gel Transport Systems (BD CultureSwab™ MaxV(+) and Remel BactiSwab) Using NCCLS M40 - A Quantitative Swab Elution Method.	2005	LR222318
Comparative Evaluation of Two New Amies Swab Transport Systems BD CultureSwab™ Max V(+) (Copan) and the Fisherfinest^® (Starplex) Swab	2005	LR222317
Modification of Swab Applicators Providing Full Compliance with NCCLS Standard M40-A	2004	LR222316
Influence of Storage Conditions on the Performance of Swab Transport Devices as Determined by the Quality Control Guidelines of NCCLS Standard M40	2004	LR222315
A Comparison of Two Swab Transport Systems in the Recovery of Fastidious Organisms	2004	LR222314

Dehydrated Culture Media

(Click column headings to sort items)

Description	Year	Literature #
A Rapid and Effective Screening Process of Animal Component Free Hydrolysates to Increase Cell Performance	2004	LR876

Direct Testing/Serology

(Click column headings to sort items)

Description	Year	Literature #
Comparison of BD Directigen™ EZ RSV and Remel X/pect™ RSV Rapid Chromatographic Immunoassays to Direct Immunofluorescence for Detection of Respiratory Syncytial Virus in Pediatric Patients	2006	LR222659
Comparison of Rapid Influenza Antigen Kits for Analytical Sensitivity and Compatibility with Viral Transport Medium.	2006	LR222254
The Effect of Various Swab Types on the Performance of the BD Directigen™ EZ FLU A+B Test and Three Other Rapid Chromatographic Immunoassay	2005	LR919
Evaluation of the BD Directigen™ EZ Flu A+B Rapid Chromatographic Immunoassay	2005	LR904
Evaluation of Lateral Flow and Membrane Flow Immunoassays for the Rapid Detection of Influenza A and Influenza B Viruses	2005	LR911
Specific Detection of Influenza A and B Virus Strains and Analytical Sensitivity Using the Directigen� Flu A+B Test	2001	LR695
Performance of the Directigen� Flu A+B Test Using Clinical Specimens from November 1999 to March 2000	2001	LR694
Evaluation of Influenza A and B Virus Storage Stability in M5 Transport Medium Using the Directigen� Flu A+B Test	2001	LR696

Identification/Susceptibility

(Click column headings to sort items)

Description	Year	Literature #
Evaluation of the Becton Dickinson Phoenix and bioM�rieux VITEK Legacy Automated Microbiology Identification and Antimicrobial Susceptibility Systems.	2006	LR222447
Evaluation of the BD Phoenix™ Automated Microbiology System for Antibiotic Susceptibility Testing of Streptococcus pneumoniae	2006	LR222403
Direct Comparison of the BD Phoenix™ Automated Microbiology System with the Microscan Walkaway for Identification and Antimicrobial Susceptibility Testing of Staphylococci, Enterococci, and Antimicrobial Susceptibilityof Streptococci.	2006	LR222405
Direct Comparison of Antimicrobial Susceptibility Testing by the BD Phoenix, bioM�rieux ViTek 2, and Disk Diffusion Test Methods as Compared to Results Generated by the CLSi Broth Microdilution Test	2006	LR222449
Comparative Study of Identification and Antimicrobial Susceptibility Testing of Enterobacteriaceae and Non-Fermentative Gram-Negative Organisms with the Phoenix™ Automated Microbiology System and Microscan Walkaway.	2006	LR222406
Comparison of Phoenix and Vitek 2 ESBL Confirmatory Tests Against E. coli and Klebsiella Isolates with Well-characterized β-lactamases	2006	LR222404
Variability in In Vitro Susceptibility Test Results for E. coli Isolates and Piperacillin/Tazobactam Using Commercial and Reference AST Methods	2005	LR222304
Performance of BD Phoenix™ in Low Inoculum Mode for the Identification of Frequently Isolated Gram-Positive Cocci	2005	LR873
Identification of Gram-Negative Bacilli in BD Phoenix™ Using the New Low Inoculum Mode	2005	LR874
Evaluation of the BD Phoenix™ for Routine Use in a Tertiary-Care Hospital Microbiology Laboratory	2005	LR886
Evaluation of the BD Phoenix System for Identification and Susceptibility Testing of Gram-Positive and Negative Clinical Isolates	2005	LR901
Evaluation of BD Phoenix Automated System and MicroScan Walkaway System for the Identification and Susceptibility Testing of Clinically Significant Gram-Positive Organisms	2005	LR890
Detection of Oxacillin Resistance in Staphylococcus aureus: Comparison of Phoenix Oxacillin and Cefoxitin MICs, MicroScan Oxacillin MIC, Oxacillin and Cefoxitin Disk Diffusion, and mecA Gene Detection.	2005	LR222305
Detection of Clindamycin and Erythromycin Resistance in Isolates of Streptococcus agalactiae using Three Commercial Systems	2005	LR882
Detection of Antimicrobial Resistance in Pseudomonas aeruginosa Using the BD Phoenix Automated Microbiology System	2005	LR883
Detection of mecA-mediated Resistance Using Cefoxitin Disk Diffusion (DD) in a Collection of Staphylococcus aureus (SA) Expressing Borderline Oxacillin MICs	2005	LR222306
Detection and Interpretation of Macrolide-Lincosamide-Streptogramin Resistance among Staphylococcus with Phoenix Automated Microbiology System and BDXpert™ System	2005	LR875
Comparison of the Vitek Legacy, Vitek 2 Colorimetric AND Phoenix Systems for Identification of Fermenting and Non-Fermenting Bacteria of Clinical Origin	2005	LR885
Comparison of MicroScan Walk-Away^®, Phoenix™ and VITEK-TWO^® Microbiology Systems Used in the Identification and Susceptibility Testing of Bacteria	2005	LR900
Comparison of BD Phoenix to Biomerieux Vitek for the Identification and Susceptibility Testing of Common Bacterial Isolates	2005	LR905
Clinical Evaluation Comparing the BD Phoenix™ Automated Microbiology System with the MicroScan^® WalkAway for Identification and Antimicrobial Susceptibility Testing of Staphylococcus aureus and Enterococcus species	2005	LR898
Accuracy of Identification in BD Phoenix™ Using the New Low Inoculum Mode	2005	LR884
Evaluation of the Phoenix 100 ID/AST System for Identification of Enterobacteriaceae and Commonly Isolated Glucose Non-Fermenting Gram-Negative Bacilli	2004	LR222340
Comparison of the BD Phoenix� (PHX) Automated Microbiology System to VIKTEK 1 (V1) for the Identification and Antimicrobial Susceptibility Testing of Gram-Negative Organisms	2004	LR813
Comparison of Four Commercially Available Systems for Antimicrobial Susceptibility Testing (AST) of Streptococcus pneumoniae	2004	LR811
Comparison of BD Phoenix Automated Microbiology System with the MicroScan Rapid Neg ID Plus Neg MIC Panel Type 30 for Identification and Susceptibility Testing of Gram-negative Bacilli	2004	LR812
Evaluation of the Etest ESBL and the BD Phoenix�, Vitek-1, and Vitek-2 Automated Instruments for Detection of Extended-Spectrum Beta-Lactamases in Multiresistant Escherichia coli and Klebsiella spp.	2002	LR741
Comparative Evaluation of the BD Phoenix and Vitek 2 Automated Instruments for Identificaiton of Isolates of the Burkholderia cepacia Complex	2002	LR732
Side by Side by Side Evaluation of Dade Microscan Walkaway 96, BD Phoenix� and BioMerieux Vitek2 for Identification Testing of a Challenge and Routine Set of Nonfermentative and Miscellaneous Gram Negative Clinical Isolates	2002	LR726
Side by Side by Side Evaluation of Dade Microscan Walkaway 96, BD Phoenix� and BioMerieux Vitek2 for Antimicrobial Susceptibility Testing of a Challenge Set of Clinical Strains	2002	LR727
Investigation of Staphylococcus aureus with Vitek-1 Erythromycin-Intermediate Susceptibilities: Comparison with Vitek-2 and Phoenix�	2002	LR740
Identification and Antimicrobial Susceptibility Testing of Clinical Isolates of Nonfermenting Gram-Negative Bacteria by the Phoenix� Automated Microbiology System	2002	LR737
Evaluation of the Phoenix� and Vitek 2� Systems for the Susceptibility Testing of Staphylococci	2002	LR728
Evaluation of the BD Phoenix� Automated Microbiology System for Fluoroquinolone Susceptibility Testing of Gram Negative Bacilli	2002	LR729
Detection of Vancomycin Resistance in Enterococci with the BD Phoenix� Automated Microbiology System	2002	LR725
Detection of Glycopeptide Intermediate or Resistant Staphylococcus aureus Strains Using BD Phoenix� Automated Microbiology System	2002	LR724
Detection of Extended Spectrum Beta-Lactamase Among Enterobacteriaceae Using BD Phoenix� Automated Microbiology System with BDXpert� System	2002	LR739
Correlation Between Phenotypic and Genotypic Traits of Glycopeptide Susceptible and Resistant Enterococcus faecium Strains	2002	LR723
Comparison of Phoenix to Vitek2 with a Diverse Group of Bacteria which are Found in Clinical Microbiology Labs	2002	LR719
An Evaluation of the BD Phoenix� Automated Microbiology System to Detect Penicillins and Cephalosporins Resistance in Streptococcus pneumoniae	2002	LR738
Comparison of the BD Phoenix� Automated Microbiology System to the Dade-MicroScan WalkAway-40 for Identification of Clinical Bacterial Isolates	2002	LR714
Comparison of the BD Phoenix� Automated Microbiology System to the Dade-MicroScan WalkAway-40 for Antimicrobial Susceptibility Testing with Gram-Negative and Gram-Positive Bacterial Isolates	2002	LR713
Comparison of Phoenix to Vitek2 Antimicrobial Susceptibility Test Performance with a Diverse Group of Bacteria which are Found in Clinical Microbiology Labs	2002	LR718
Antimicrobial Susceptibility Testing for Ten 5-Fluoroquinolones Using the BD Phoenix� Automated Microbiology System	2002	LR717
Evaluation of the New Automated Phoenix� System for Detection of Special Resistance Mechanisms	2001	LR711
Detection of Oxacillin Resistance in Coagulase Negative Staphylococci with Phoenix™	2001	LR710
Evaluation of the BD Phoenix� Automated Microbiology System in Detecting Glycopeptide Resistance Among Enterococci Isolates	2001	LR722
The Importance of Extended-Spectrum β-Lactamase (ESBL) Screening Tests in Rapid Automated Antimicrobial Susceptibility Testing (AST)	2001	LR704
Performance of the BD Phoenix� Automated Microbiology System in the Identification of Gram-Positive Bacteria	2001	LR684
Identification Accuracy of Gram-Negative Bacilli in the BD Phoenix� Automated Microbiology System	2001	LR686
Evaluation of the Performance of New Phoenix� Automated Microbiology System on Gram-Negative Rods	2001	LR680
Evaluation of the New Phoenix� Automated Microbiology System on Gram-Positive Cocci	2001	LR681
Evaluation of the BD Phoenix™ Automated Microbiology System's Susceptibility Test Function for Gram Positive Organisms	2001	LR697
Evaluation of the BD Phoenix™ Automated Microbiology System in Identification and AST of Clinical Isolates of Pseudomonas spp. and Other Nonfermenting Gram-negative Bacteria	2001	LR690
Detection of Resistance to Broad Spectrum β-Lactam Antimicrobics in Nonfermentative Gram-Negative Bacteria Using the BD Phoenix� Automated Microbiology System	2001	LR688
Detection of Exteded-Spectrum Beta-Lactamase Production and Beta-Lactam Resistance in Escherichia coli and Klebsiella Using the BD Phoenix� Automated Microbiology System	2001	LR685
Correlation Between Phenotypic Characteristics and Glycopeptide Susceptibility in Enterococcus faecium	2001	LR687
Antimicrobial Susceptibility Testing and ESBL Production in Clinical Isolates of Proteus Mirabilis: An Evalution with the BD Phoenix� Automated Microbiology System	2001	LR689
Rapid Identification of Resistant Gram-Negative Isolates in the Phoenix� Automated Microbiology System	2000	LR646
Evaluation to Detect Gram-Negative Bacterial Resistances with Eight Broad-Spectrum Antimicrobics in the Phoenix� Automated Microbiology System	2000	LR643
Evaluation of the Phoenix� Automated Microbiology System for the Detection of Gram-Negative Bacterial Resistance to Aminoglycosides	2000	LR648
Determining Beta-Lactam Resistance among Gram-Negative Isolates in the Phoenix� Automated Microbiology System	2000	LR649
Detection of Resistance to Beta-lactam Antibiotics in Combination with Beta-Lactamase Inhibitors in Gram-Negative Bacteria by the Phoenix� Automated Microbiology System	2000	LR655
Detection of High Level Aminoglycoside Resistance (HLAR) in Enterococci with the Phoenix� Automated Microbiology System	2000	LR652
Detection of ESBL Producing E.coli and Klebsiella in the Phoenix� Automated Microbiology System	2000	LR647
Comparison of the Phoenix� Automated Microbiology System and MicroScan WalkAway�-96 for In Vitro Susceptibility Testing of Gram-Negative Bacilli	2000	LR653
Assessment of the Phoenix� Automated Microbiology System in the Identification of a Variety of Gram-Negative Bacilli	2000	LR645
An Evaluation of the Phoenix� Automated Microbiology System for Extended Spectrum Beta-Lactamase Detection	2000	LR654
Comparison of Phoenix� and Vitek� Automated Susceptibility Test Systems for Performance with Acinetobacter baumannii complex and Pseudomonas aeruginosa isolates	2000	LR661
Evaluation of the Phoenix� Automated Microbiology System for Detection of (i) Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella spp., and of (ii) Ciprofloxacin-Resistant Acinetobacter spp. and Pseudomonas aeruinosa European Clinical Isolates	2000	LR669
Detection of beta-Lactam Resistance in Staphylococci with the Phoenix� Automated Microbiology System	2000	LR668
A Performance Evalution of Phoenix� Automated Microbiology System in detecting resistance to Linezolid, Azithromycin, Clarithromycin and Quinupristin-dalfopristin among Staphylococcal and Enterococcal isolates	2000	LR667
Rapid Automated Identification of Gram-Positive and Gram-Negative Bacteria in the Phoenix� System	1999	LR650
Rapid Antimicrobial Susceptibility Testing in Phoenix�	1999	LR651
Rapid Susceptibility Testing of Gram Positive Organisms: A Preliminary Study of the Phoenix� System	1999	LR641
Rapid Detection of Beta-lactamase Production in Penicillin Sensitive Staphylococci by the Phoenix� Automated ID/AST System	1999	LR642
Preliminary Evaluation and Overview of Phoenix�, A New Automated ID/AST System	1999	LR637
Identification of Gram-Negative Bacteria in the Phoenix� System	1999	LR638
Detection of Vancomycin (VA) Resistance in Enterococci with the Phoenix� System	1999	LR636
Detection of Oxacillin Resistance in Staphylococcal Species with the Phoenix� Sytem	1999	LR635
Comparative Studies of Antibiotic Susceptibility of Stenotrophomonas maltophilia with Trimethoprim/Sulfonamethoxazole Using Different Testing Methodologies	1999	LR640
Antibiotic Susceptibility Testing of Stenotrophomonas maltophilia with Trimethorpim/Sulfamethoxazole Using the Phoenix� System	1999	LR639
Detection of Gram-Negative Bacterial Resistance to Fluoroquinolone Agents in the Phoenix� Automated Microbiology System	1999	LR656

Molecular Diagnostics

(Click column headings to sort items)

Description	Year	Literature #
Repeatability Evaluation of Specimens Tested with the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR Technology	2009	LR222993
Evaluation of the BD ProbeTec CTQ Amplified DNA Assay for Detection of the New Chlamydia trachomatis Variant in Sweden	2009	LR222995
Analytical Reproducibility of the BD Viper™ System with XTR™ Technology (extracted mode) for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae When Using the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays	2009	LR222994
Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology with the BD ProbeTec™ Neisseria gonorrhoeae (GC) Q^x Amplified DNA Assay	2009	LR222950
Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology Utilizing the BD ProbeTec™ Chlamydia trachomatis (CT) Q^x Amplified DNA Assay	2009	LR222951
Endocervical Swab Performance from STD Clinics with the BD ProbeTec™ Chlamydia trachomatis (CT) Q^x Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Q^x Amplified DNA Assay on the BD Viper™ System with XTR™ Technology (BD Viper System with XTR)	2009	LR222949
Vaginal Swab Performance on the BD Viper™ System with XTR™ Technology (Extracted Mode) for Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) at Family Planning / OB/GYN Collection Sites - Perspectives in Clinical Care	2009	LR222943
Reproducibility of the BD Viper™ System with XTR™ Technology (Extracted Mode) with PreservCyt® Liquid Based Cytology Medium	2009	LR222944
Performance of the BD ProbeTec&rrade; CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR™ Technology Using Male Urine Samples	2009	LR222942
Performance of SurePath® Preservative Fluid Specimens with the BD ProbeTec CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR™ Technology	2009	LR222945
The Measurement of Reliability of the BD Viper™ System	2008	LR222822
Work Flow Efficiencies and Operator Advantages Determined for the BD™ Viper ER and the BD™ ProbeTec	2008	LR222815
Performance of the BD ProbeTec™CT Qx and GC Qx Amplified DNA Assays* with Urine and Vaginal Swab Specimens in the Presence of Potential Interfering Substances	2008	LR222820
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on Endocervical and Vaginal Swabs with the BD ProbeTec™ CTQx and GCQx Amplified DNA Assays* on the BD Viper™ System in Extracted Mode*	2008	LR222818
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine using the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays on the BD Viper™ System in Extracted Mode	2008	LR222817
Comparison of Workflow and Analytical Sensitivity with Urine Specimens between the BD ProbeTec™ ET System and the BD Viper™ System in Extracted Mode.	2008	LR222816
Clinical Evaluation of the BD Viper™ System and the BD ProbeTec™ CTQx Amplified DNA Assay (CTQx) for the Direct Qualitative Screening of Chlamydia trachomatis (CT) in Female Endocervical, Female Vaginal, and Female Urine Specimens	2008	LR222814
Reliability of the BD Viper™ System in Extracted Mode for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae	2008	LR222821
Performance of the BD Viper™ System in Extracted Mode* with the New BD ProbeTec™ Chlamydia trachomatis and Neisseria gonorrhoeae Qx Amplified DNA Assays*	2008	LR222813
Performance of the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays with PreservCyt&red; Specimens on the BD Viper™ System in Extracted Mode	2008	LR222811
Evaluation of the BD Viper™ System in Extracted Modeto Detect Chlamydia trachomatis and Neisseria gonorrhoeae in BD SurePath™ and Preservcyt® Cytology Specimens	2008	LR222819
Evaluation of the BD Viper™ System in Extracted Mode* to Detect Chlamydia trachomatis and Neisseria gonorrhoeae in Male Swab and Urine Specimens	2008	LR222812
Validation of the BD ProbeTec™ Urine Preservative Transport (UPT) for use with the BD ProbeTec™ ET System for Detection of Chlamydia Trachomatis	2005	LR908
Time-Motion Comparison of BD ProbeTec™ ET System and Gen-Probe^® APTIMA^® Combo 2™ Assay for Chlamydial and Gonorrhea Diagnosis	2005	LR903
Performance of the BD ProbeTec™ Urine Preservative Transport with Second Generation Amplified DNA Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on the BD ProbeTec™ ET System	2005	LR907
Feasibility of Using TriPath Imaging,^® Inc. SurePath™ Preservative Fluid with the BD ProbeTec™ ET CT/GC Amplified DNA Assays*	2005	LR881
Evaluation of the BD ProbeTec™ Urine Preservative Transport (UPT) for Use With the BD ProbeTec™ ET Neisseria gonorrhoeae Amplified Assays	2005	LR887
Evaluation of the BD ProbeTec ET System for Chlamydia trachomatis and Neisseria gonorrhoeae Infections of the Endocervix and Oropharynx in Women	2005	LR902
Detection of Herpes Simplex Virus Type 1 and Type 2 DNA by Strand Displacement Amplification on the BD ProbeTec™ ET System	2005	LR880
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Vaginal Swabs Using Second Generation Assays on the BD ProbeTec™ ET System	2005	LR910
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical Swabs: A Comparative Evaluation of Three Commercial Kits	2005	LR906
Compatibility of Accurun^® and Amplichek™ Positive Controls with the BD ProbeTec™ ET CT/GC Amplified DNA Assays	2005	LR879
Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) by Reverse Transcriptase-Strand Displacement Amplification on the BD ProbeTec� ET System	2004	LR802
Detection of Herpes Simplex Virus Type 1 by Strand Displacement Amplification on the BD ProbeTec� ET System	2003	LR753
Take Action on HEDIS	2003	LR691
Comparison of the BD ProbeTec ET and Gen Probe PACE 2 Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Endocervical Samples	2003	LR770
Comparison of Two Nucleic Acid Amplification Tests to Culture for the Detection of Pharyngeal	2002	LR716
Detection of Community Acquired Pneumonia Pathogens in Lower Respiratory Specimens Using the BD ProbeTec™ ET System	2002	LR797
Detection of Legionella pneumophila, Mycoplasma pneumoniae, and the Chlamydiaceae Family from a Single Throat Swab Using the BD ProbeTec™ ET System	2002	LR796
Comparison of Three Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis in Urine Specimens	2002	LR715
BDProbeTec™ ET CT/GC Amplified DNA Assay Wet Swab Transport for use with Endocervical and Urethral Swab	2002	LR730
Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in Pooled Urine and Cervical Swab Specimens by BDProbeTec� ET.	2001	LR699
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Enzyme Immunoassay, Culture, and Three Nucleic Acid Amplification Tests	2001	LR625
Multicenter Evaluation of the BDProbeTec� ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral Swabs	2001	LR679
In-House Verification of the BDProbeTec� (BDP) Chlamydia trachomatis (CT) and Neisseria gonorrohoeae (NG) Amplified Assay using Abbott LCx (LCX) STD Swab Specimen Collection System	2001	LR693
Evaluation of Vaginal Swab Specimens for Detection of Neisseria gonorrhoeae and Chlamydia trachomatis by BDProbeTec� ET	2001	LR692
Detection of Chlamydia pneumoniae and Other Organisms of the Chlamydiaceae Family by Strand Displacement Amplification on the BD ProbeTec� ET System*	2001	LR795
Clinical Comparison of the BDProbeTec� ET Amplified DNA Assay and the Abbott LCx for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Endocervical Swabs and Urine Samples	2001	LR683
A Long Term Evaluation of the BDProbeTec� ET System for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in a High Volume Clinical Laboratory	2001	LR709
Performance Comparison of the Becton Dickinson ProbeTec System for Direct Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urine Specimens in Comparison With the Roche Cobas System	2000	LR733
Universal Probes for Homogeneous Real-Time Fluorescent Detection of Strand Displacement Amplification Products	2000	LR623
Strand Displacement Amplification for the Diagnosis of Chlamydia and Gonorrhea in North Queensland	2000	LR664
Experimental Evaluation of Chlamydia trachomatis and Neisseria gonorrhoeae Detection Sensitivity of BDProbeTec� ET	2000	LR663
Evaluation of the BDProbeTec� ET System for the Direct Detection of Mycobacterium tuberculosis Complex from Clinical Respiratory Specimens using Strand Displacement Amplification Technology	2000	LR620
Evaluation of the BDProbeTec� ET Assay for Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae Infections	2000	LR662
Detection of Mycoplasma pneumoniae by Strand Displacement Amplification on the BDProbeTec™ ET System	2000	LR622
Detection of Legionella pneumophila by Strand Displacement Amplification on the BDProbeTec� ET System	2000	LR624
Detection of Bordetella pertussis by Homogeneous Strand Displacement Amplification for use on the BDProbeTec� ET System	2000	LR621
Correlation of Three Commercial Nucleic Acid Amplification Techniques and Conventional Assys for Chlamydia trachomatis and Neisseria gonorrhoeae in Female Endocervical Swab and Urine Specimens	2000	LR666
Comparison of BDProbeTec� ET, Abbott LCx�, Roche COBAS AMPLICOR�, and GenProbe PACE 2� Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Swab Specimens	2000	LR665
Evaluation of the BDProbeTec� ET Thermophilic Strand Displacement Assay for the Simultaneous Amplification and Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae.	1999	LR617
Evaluation of the BDProbeTec� ET System on Urine and Genital Specimens for the Identification of Chlamydia and Gonorrhea Infections in Adolescents	1999	LR618
The Development of Three Strand Displacement Amplification Assays for Culture Confirmation of Mycobacterium tuberculosis Complex, Mycobacterium avium Complex and Mycobacterium kansasii on the BDProbeTec™ ET System	1999	LR602
Multicenter Evaluation of the BDProbeTec� ET System in Detecting Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical and Urine Specimens in Women	1999	LR616
Multicenter Evaluation of the BDProbeTec� ET System in Detecting Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical and Urine Specimens in Women	1999	LR613
Evaluation of the BDProbeTec� ET System on Urine and Endocervical Specimens for the Identification of Chlamydia and Gonorrhea Infections.	1999	LR612
Evaluation of the BDProbeTec� ET System for N. gonorrhoeae and C. trachomatis Diagnosis Using Urine or Swab Specimens from Females Attending STD Clinics	1999	LR614
Evaluation of the BDProbeTec™ ET* System for the Direct Detection of Mycobacterium tuberculosis Complex from Smear Negative Respiratory Samples	1999	LR599
Evaluation of Swab Interfering Substances on the BDProbeTec™ ET Chlamydia trachomatis and Neisseria gonorrhoeae Amplified DNA Assay	1999	LR604
Evaluation of Room Temperature Storage and Stability of Specimens in the BDProbeTec� ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Female Endocervical and Female and Male Urine Specimens	1999	LR615
Evaluation of BDProbeTec� ET for the Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Female Urogenital Specimens	1999	LR610
Effect of Potentially Interfering Substances on the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples Using the BDProbeTec™ ET System	1999	LR600
Development of a Homogeneous DNA Amplification Test for the Real-Time, Direct Detection of Mycobacterium tuberculosis DNA on the BDProbeTec™ ET Instrument	1999	LR601
Comparison of the BDProbeTec� ET System to Ligase Chain Reaction and Polymerase Chain Reaction for Detection Chlamydia trachomatis and Neisseria gonorrhoeae	1999	LR611
Clinical Evaluation of the BDProbeTec� ET System in Detecting C. Trachomatis and N. Gonorrhoeae in Endocervical and Female Urine Specimens.	1999	LR609
A Method to Enumerate Chlamydia trachomatis by Counting DFA Stained Elementary Bodies on a Printed Microscope Slide	1999	LR603
Comparison of the BDProbeTec� ET System to Ligase Chain Reaction (LCR) for the Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC)	1999	LR619
Strand Displacement Amplification and Homogeneous Real-Time Detection Incorporated in a Second-Generation DNA Probe System, BDProbeTecET	1999	LR598
Evaluation of the BDProbeTec� ET Oven to Render Microorganisms Nonviable Prior to Testing on the BDProbeTec� ET System	1997	LR631

Mycobacteria Testing

(Click column headings to sort items)

Description	Year	Literature #
Comparison of clarithromycin susceptibility of Mycobacterium avium complex using the NCCLS BACTEC™ 460 method and the BACTEC™ MGIT™ 960.	2005	LR913
Susceptibility Testing of Mycobacterium tuberculosis to Anti-Tuberculosis Drugs: BACTEC� MGIT� 960 vs BACTEC� 460TB System	2000	LR660

Prepared Media

(Click column headings to sort items)

Description	Year	Literature #
Screening for Nasal Carriage of Methicillin-Resistant Staphylococcus aureus (MRSA): Reduction of Turnaround Time and Workload by the use of BBL™ CHROMagar™ MRSA.	2007	LR222707
Comparison of the IDI-MRSA™ Assay to Culture Using BBL™ CHROMagar™ MRSA for Detection of MRSA from Nasal Surveillance Cultures in an At-Risk Population	2007	LR222708
The Ability of BBL CHROMagar MRSA to Detect Community-Associated Methicillin Resistant S. aureus	2005	LR895
Reliability of Coagulase Testing from BBL™ CHROMagar™ MRSA	2005	LR893
Rapid Identification of Yeast Isolates using BD BBL™ CHROMagar™ Candida	2005	LR894
Isolation of Uropathogens on Chromogenic Agar versus Standard Dipslides from Urine Collected with and without Preservative	2005	LR892
Evaluation of New BBL™ CHROMagar™ Listeria for Isolation of Listeria monocytogenes in Foods	2005	LR916
Evaluation of BBL™ CHROMagar™ Salmonella: AOAC Performance Tested Method^SM	2005	LR917
Evaluation of BBL™ CHROMagar™ Orientation Agar for Routine Urine Cultures in a High Volume Clinical Laboratory	2005	LR896
Evaluation of BBL™ CHROMagar™ MRSA for Detection of Methicillin-Resistant Staphylococcus aureus from Surveillance Swabs	2005	LR889
Evaluation of BBL™ CHROMagar™ Listeria: AOAC Performance Tested Method^SM	2005	LR918
Enhanced Detection of Methicillin Resistant Staphylococcus aureus Using Chromogenic MRSA Media Compared to Traditional Culture Methods	2005	LR897
Use of BBL� CHROMagar� Orientation Media for the Identification and Enumeration of Urinary Tract Pathogens: Comparison to Routine Culture Techniques	2004	LR808
The Ability of BBL� CHROMagar� Orientation to Recover Corynebacterium urealyticum	2004	LR804
Growth Characteristics of Moulds on BBL� CHROMagar� Candida Medium	2004	LR810
Evaluation of a New Commercially Available Rapid Assimilation of Trehalose (RAT) Test for the Identification of Candida glabrata	2004	LR809
Detection of Methicillin-Resistant Staphylococcus aureus Using a New Medium, BBL� CHROMagar� MRSA, Compared to Current Methods	2004	LR803
Cost Effectiveness of BBL� CHROMagar� Orientation Medium for Routine Urine Cultures	2004	LR806
Comparison of Two Prototypes of BBL� CHROMagar� MRSA to Conventional Media for the Detection of Methicillin Resistant Staphylococcus aureus in Clinical Samples	2004	LR805
Comparison of BBL� CHROMagar� O157 to Sorbitol MacConkey for Recovery of E. coli O157 in Stool Cultures	2004	LR807
Comparison of BBL™ CHROMagar™ Listeria to Currently Recommended Media for the Isolation of Listeria monocytogenes from Food Sources	2003	LR915
Practical Bench Comparison of BBL� CHROMagar� Orientation and Standard 2-Plate Media for Urine Cultures	2003	LR766
Comparison of BBL�CHROMagar� Staph aureus to Conventional Media for the Detection of Methicillin Susceptible and Methicillin Resistant Staphylococcus aureus in Clinical Respiratory Samples	2003	LR765
BBL� CHROMagar� Staph aureus is Superior to Mannitol Salt for Detection of Staphylococcus aureus in Complex Mixed Infections	2003	LR777
BBL� CHROMagar� Candida as the Sole Primary Medium for the Isolation of Yeasts and as a Source Medium for the Rapid Assimilation of Trehalose (RAT) Test	2003	LR767
Comparison of BBL� CHROMagar� Staph aureus to other Commonly Used Media for the Presumptive Identification of Staphylococcus aureus	2002	LR745
Evaluation of BBL� CHROMagar� Candida as the Primary Isolation Medium for Use With Two Confirmatory Identification Systems, IDS RapID Yeast Plus System and API 20C AUX	2001	LR698